Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders (QoQ) (2015 - 2026)
Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 171.73 Mn | 142.80 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.03% |
| Dec 31, 2025 | -111.49% |
| Sep 30, 2025 | -11.41% |
| Jun 30, 2025 | -46.04% |
| Mar 31, 2025 | 80.09% |
| Dec 31, 2024 | -148.36% |
| Sep 30, 2024 | -194.16% |
| Jun 30, 2024 | 50.86% |
| Mar 31, 2024 | 29.65% |
| Dec 31, 2023 | -98.43% |
| Sep 30, 2023 | 22.64% |
| Jun 30, 2023 | -176,544.17% |
| Mar 31, 2023 | -99.95% |
| Dec 31, 2022 | 194.38% |
| Sep 30, 2022 | -14.99% |
| Jun 30, 2022 | 18.65% |
| Mar 31, 2022 | 71.32% |
| Dec 31, 2021 | -160.04% |
| Sep 30, 2021 | -31.52% |
| Jun 30, 2021 | -167.75% |